| PCa | Prostate Cancer |
| ADT | Androgen Deprivation Therapy |
| CRPC | Castration Resistant Prostate Cancer |
| AR | Androgen Receptor |
| AR-FL | Full-Length AR |
| NTD | N-Terminal Domain |
| DBD | DNA-Binding Domain |
| LBD | Ligand Binding Domain |
| AR-Vs | AR splice Variants |
| DNMTs | DNA-methyltransferases |
| HATs | Histone Acetyltransferases |
| HDACs | Histone Deacetylases |
| CTCs | Circulating Tumor Cells |
| CYP17A1 | Cytochrome P450 family 17 subfamily A polypeptide 1 |
| CYP11A1 | Cytochrome P450 family 11 subfamily A polypeptide 1 |
| DHEA | Dehydroepiandrosterone |
| DHEA-S | Dehydroepiandrosterone sulfate |
| DHT | Dihydrotestosterone |
| Akt | Protein kinase B |
| PI3K | Phosphoinositide 3-kinase |
| PTEN | Phosphatase and tensin homolog |
| mTOR | Mammalian target of rapamycin |
| EZH2 | Enhancer of zeste homolog 2 |
| BRD4 | Bromodomain containing protein 4 |
| BET | Bromodomain and extra terminal family proteins |